Jelena D. Feenstra-Milosevic
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemia.
Journal: Blood
Published: August 19, 2025
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.
Journal: Blood
Published: August 19, 2025
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
Journal: American journal of hematology
Published: November 30, 2022
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Journal: Nature communications
Published: January 05, 2022
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.
Journal: American journal of hematology
Published: November 29, 2021
Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera.
Journal: Blood
Published: March 26, 2020
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Journal: Nature communications
Published: January 30, 2020
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML.
Journal: International journal of molecular sciences
Published: January 21, 2019
CDK6 coordinates JAK2 V617F mutant MPN via NF-κB and apoptotic networks.
Journal: Blood
Published: August 31, 2018
8p11 myeloproliferative syndrome: diagnostic challenges and pitfalls.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: August 30, 2016
Last Updated: 09/26/2026